IMC-S118AI

BIOLOGICAL2 trials

Sponsors

Immunocore Limited, Immunocore Ltd

Conditions

Diabetes Type 1Type 1 DiabetesType 1 Diabetes (T1D)

Phase 1

Study of IMC-S118AI in Type 1 Diabetes

Not yet recruitingNCT07493122

Immunocore LtdDiabetes Type 1, Type 1 Diabetes, Type 1 Diabetes (T1D)

Start: 2026-04-01End: 2030-11-01Target: 154Updated: 2026-03-25

A Dose-Escalation Study Evaluating the Safety and Pharmacokinetics of IMC-S118AI in HLA-A*02:01-Positive Participants With Type 1 Diabetes

Not yet recruitingCTIS2025-524449-28-00

Immunocore LimitedType 1 Diabetes

Target: 20Updated: 2026-07-17